| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8746449 | Journal of Global Antimicrobial Resistance | 2017 | 15 Pages |
Abstract
We found higher non-susceptibility rates to vancomycin and metronidazole than most previous studies, while tigecycline resistance rates are very low in northern Israel, rendering it a potential agent for treating CDI.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Linda Tkhawkho, Orna Nitzan, Nina Pastukh, Diana Brodsky, Karen Jackson, Avi Peretz,